Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Insulin Receptor Blocking Peptide (AC1290)
Cat.#: ACPP-1290
Specifications
Despition Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1341 Pax2 Blocking Peptide (AC1341) 250 µg inquiry ACPP-1001 Recombinant Human DEGA Protein (6×His Tag) (AC1001) 50 µg inquiry ACPP-1269 Mouse GDNF Protein (AC1269) 2 µg inquiry ACPP-1550 Rat FGF 1 Protein (AC1550) 10 µg inquiry ACPP-1185 Mouse FGF 1 Protein (AC1185) 10 µg inquiry ACPP-1388 Human FDX1 Protein (AC1388) 5 µg inquiry ACPP-1543 Human AKR1C3 Protein (AC1543) 5 µg inquiry ACPP-1278 EAAT1 Blocking Peptide (AC1278) 250 µg inquiry ACPP-1685 Human MOG Protein (AC1685) 10 µg inquiry ACPP-1641 Adenylate cyclase 1 Blocking Peptide (AC1641) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket